Mangalam Drugs & Organics Limited

NSE MANGALAM.NS

Mangalam Drugs & Organics Limited Inventory for the year ending March 31, 2024: USD 14.82 M

Mangalam Drugs & Organics Limited Inventory is USD 14.82 M for the year ending March 31, 2024, a -11.37% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Mangalam Drugs & Organics Limited Inventory for the year ending March 31, 2023 was USD 16.73 M, a 8.45% change year over year.
Mangalam Drugs & Organics Limited Inventory for the year ending March 31, 2022 was USD 15.42 M, a 92.75% change year over year.
Mangalam Drugs & Organics Limited Inventory for the year ending March 31, 2021 was USD 8.00 M, a -7.01% change year over year.
Mangalam Drugs & Organics Limited Inventory for the year ending March 31, 2020 was USD 8.60 M, a -18.59% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

NSE: MANGALAM.NS

Mangalam Drugs & Organics Limited

CEO	Mr. Govardhan Murlidhar Dhoot
IPO Date	May 23, 2005
Location	India
Headquarters	Rupam Building
Employees	432
Sector	Healthcare
Industries Pharmaceuticals Chemicals & Advanced Materials Cleaning Supplies Drugstores & Retail Pharmacies Personal Care Petrochemicals

Description

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.

Key trends

Past 5 years